Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors
出版年份 2014 全文链接
标题
Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors
作者
关键词
Epidermal growth factor inhibitor, Tyrosine kinase inhibitor, Skin inflammation, Antimicrobial peptide, Cytokine, Chemokine
出版物
ARCHIVES OF TOXICOLOGY
Volume 88, Issue 6, Pages 1189-1203
出版商
Springer Nature
发表日期
2014-04-25
DOI
10.1007/s00204-014-1244-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- (2013) Grace K. Dy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cutaneous manifestations of anti-angiogenic therapy in oncology: Review with focus on VEGF inhibitors
- (2013) Rim S. Ishak et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Platelet-derived growth factor signaling in mesenchymal cells
- (2013) Johanna Donovan Frontiers in Bioscience-Landmark
- Stem Cells behind the Barrier
- (2013) Michael Cangkrama et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The cutaneous innate immune response in patients with atopic dermatitis
- (2013) I-Hsin Kuo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation
- (2013) Daisuke Nanba et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Contribution of Tight Junction Proteins to Ion, Macromolecule, and Water Barrier in Keratinocytes
- (2013) Nina Kirschner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- From Bench to Bedside: Lessons Learned in Translating Preclinical Studies in Cancer Drug Development
- (2013) C. H. Lieu et al. JNCI-Journal of the National Cancer Institute
- Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials
- (2013) Liang Shi et al. LUNG CANCER
- Claudins and the Modulation of Tight Junction Permeability
- (2013) Dorothee Günzel et al. PHYSIOLOGICAL REVIEWS
- Skin Rash could Predict the Response to EGFR Tyrosine Kinase Inhibitor and the Prognosis for Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
- (2013) Hong-bing Liu et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of Adverse Effects of Anti-EGFR Therapy
- (2013) F. Mascia et al. Science Translational Medicine
- Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation
- (2013) B. M. Lichtenberger et al. Science Translational Medicine
- Reduced Expression of Epidermal Growth Factor Receptor, E-Cadherin, and Occludin in the Skin of Flaky Tail Mice Is Due to Filaggrin and Loricrin Deficiencies
- (2012) Kozo Nakai et al. AMERICAN JOURNAL OF PATHOLOGY
- Characterization of EGFR and ErbB2 expression in atopic dermatitis patients
- (2012) Annika Sääf et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Mechanisms of cardiotoxicity associated with ErbB2 inhibitors
- (2012) Carmine Fedele et al. BREAST CANCER RESEARCH AND TREATMENT
- Intercellular contact augments epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3)-activation which increases podoplanin-expression in order to promote squamous cell carcinoma motility
- (2012) Mizue Fujii et al. CELLULAR SIGNALLING
- Notch Activation by the Metalloproteinase ADAM17 Regulates Myeloproliferation and Atopic Barrier Immunity by Suppressing Epithelial Cytokine Synthesis
- (2012) Aditya Murthy et al. IMMUNITY
- EGFR through STAT3 modulates ΔN63α expression to sustain tumor-initiating cell proliferation in squamous cell carcinomas
- (2012) Francesca Ripamonti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation
- (2012) Claus-Werner Franzke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutaneous side effects of inhibitors of the RAS/RAF/MEK/ERK signalling pathway and their management
- (2012) I. Manousaridis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Distinct contribution of stem and progenitor cells to epidermal maintenance
- (2012) Guilhem Mascré et al. NATURE
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
- (2012) Fei Su et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma
- (2012) Ramaprasada Rao Kotipatruni et al. PLoS One
- The Emerging Role of Peptides and Lipids as Antimicrobial Epidermal Barriers and Modulators of Local Inflammation
- (2012) N.K. Brogden et al. SKIN PHARMACOLOGY AND PHYSIOLOGY
- Nuclear functions and subcellular trafficking mechanisms of the epidermal growth factor receptor family
- (2012) Ying-Nai Wang et al. Cell and Bioscience
- RAF inhibition and induction of cutaneous squamous cell carcinoma
- (2011) Caroline Robert et al. CURRENT OPINION IN ONCOLOGY
- Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors
- (2011) Yevgeniy Balagula et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors
- (2011) O. Segatto et al. JOURNAL OF CELL SCIENCE
- Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- (2011) Nikhil Wagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic and Clinicopathologic Associations of OncogenicBRAFin Metastatic Melanoma
- (2011) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation
- (2011) Jung-Mao Hsu et al. NATURE CELL BIOLOGY
- Tumor control versus adverse events with targeted anticancer therapies
- (2011) Dorothy M. K. Keefe et al. Nature Reviews Clinical Oncology
- Management of Skin Toxicity Associated with Cetuximab Treatment in Combination with Chemotherapy or Radiotherapy
- (2011) C. Pinto et al. ONCOLOGIST
- Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17
- (2011) Thorsten Maretzky et al. Nature Communications
- Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion
- (2010) K. Potthoff et al. ANNALS OF ONCOLOGY
- Mutaciones de sensibilidad y resistencia del gen epidermal growth factor receptor (EGFR) en el cáncer de pulmón de célula no pequeña: una realidad clínica
- (2010) Álvaro Taus et al. ARCHIVOS DE BRONCONEUMOLOGIA
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
- (2010) Hui Cheng et al. CIRCULATION RESEARCH
- Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibition Results in Biphasic Alteration of Epidermal Homeostasis with Keratinocytic Apoptosis and Pigmentation Disorders
- (2010) K. Schad et al. CLINICAL CANCER RESEARCH
- Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1
- (2010) Wei Yi et al. EXPERIMENTAL CELL RESEARCH
- Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes
- (2010) Mayuko Yamaki et al. EXPERIMENTAL DERMATOLOGY
- Activated Protein C Enhances Human Keratinocyte Barrier Integrity via Sequential Activation of Epidermal Growth Factor Receptor and Tie2
- (2010) Meilang Xue et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGFR (Trans)activation Mediates IL-8 and Distinct Human Antimicrobial Peptide and Protein Production following Skin Injury
- (2010) Amanda S. Büchau JOURNAL OF INVESTIGATIVE DERMATOLOGY
- EGFR and IL-1 Signaling Synergistically Promote Keratinocyte Antimicrobial Defenses in a Differentiation-Dependent Manner
- (2010) Andrew Johnston et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- EGFR Signaling and Drug Discovery
- (2010) Georg Lurje et al. ONCOLOGY
- Computational modeling of the EGFR network elucidates control mechanisms regulating signal dynamics
- (2009) Dennis YQ Wang et al. BMC Systems Biology
- Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis
- (2009) Kim B. Jensen et al. Cell Stem Cell
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- (2009) Jorg Hartmann et al. CURRENT DRUG METABOLISM
- Mechanisms of tumor resistance to EGFR-targeted therapies
- (2009) Elizabeth A Hopper-Borge et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Injury Is a Major Inducer of Epidermal Innate Immune Responses during Wound Healing
- (2009) K. Markus Roupé et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- EGFR Regulates the Expression of Keratinocyte-Derived Granulocyte/Macrophage Colony-Stimulating Factor In Vitro and In Vivo
- (2009) Francesca Mascia et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
- (2009) R. E. Eilers et al. JNCI-Journal of the National Cancer Institute
- Epidermal homeostasis: a balancing act of stem cells in the skin
- (2009) Cédric Blanpain et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Skin toxicities associated with epidermal growth factor receptor inhibitors
- (2009) Tianhong Li et al. Targeted Oncology
- Beyond Wavy Hairs
- (2008) Marlon R. Schneider et al. AMERICAN JOURNAL OF PATHOLOGY
- Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib
- (2008) M. E. Lacouture et al. ANNALS OF ONCOLOGY
- Role of platelet-derived growth factors in physiology and medicine
- (2008) J. Andrae et al. GENES & DEVELOPMENT
- The epidermal growth factor receptor ligands at a glance
- (2008) Marlon R. Schneider et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
- (2008) Stephan Barrientos et al. WOUND REPAIR AND REGENERATION
- Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab
- (2007) Fernando Rivera et al. ACTA ONCOLOGICA
- The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation
- (2007) Saveria Pastore et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started